TBRIA (calcitonin-salmon) for the Treatment of Postmenopausal Osteoporosis

TBRIA (calcitonin-salmon [rDNA origin] delayed release tablet) is the first oral recombinant salmon calcitonin, developed by Tarsa Therapeutics, for the treatment of postmenopausal osteoporosis.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news